EGM
KERX

Engineers Gate Manager’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Engineers Gate Manager’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,300
Closed -$102K – 935
2017
Q3 		$102K Buy
+14,300
New +$103K 0.01% 665
2015
Q4 		– Sell
-59,882
Closed -$211K – 874
2015
Q3 		$211K Buy
+59,882
New +$401K 0.02% 590

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Engineers Gate Manager's KERX Position: Q4 2017 in Review

Engineers Gate Manager sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2017, closing a stake of 14,300 shares — an estimated $102K sold.

Engineers Gate Manager first reported a position in KERX in Q3 2015 and held it in 2 quarters. The position peaked at $211K in Q3 2015. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

  • Engineers Gate Manager reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Engineers Gate Manager sold 14,300 Keryx Biopharmaceuticals Inc shares in Q4 2017, an estimated $102K.
  • Engineers Gate Manager first reported a position in Keryx Biopharmaceuticals Inc in Q3 2015 and held it in 2 quarters.
  • Engineers Gate Manager's Keryx Biopharmaceuticals Inc position peaked at $211K in Q3 2015.
  • 129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Engineers Gate Manager's 13F filing for Q4 2017, filed 1 Feb 2018.